X0303 4/A 2009-12-31 2010-01-05 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001412292 Darazsdi Daniel G 929 NORTH FRONT STREET WILMINGTON NC 28401 0 1 0 0 Chief Financial Officer Common Stock 11482 D Stock Options (to buy) 26.64 2010-02-18 2019-02-18 Common Stock 60000 60000 D Stock Options (to buy) 20.64 2009-11-20 2018-11-20 Common Stock 22500 22500 D Stock Options (to buy) 39.01 2009-10-03 2018-10-03 Common Stock 22500 22500 D Stock Options (to buy) 44.78 2009-02-20 2018-02-20 Common Stock 45000 45000 D Stock Options (to buy) 35.35 2008-10-01 2017-10-01 Common Stock 90000 90000 D This filing is being made to include in the Reporting Person's holdings shares acquired under the automatic dividend reinvestment provision of the Company's Employee Stock Purchase Plan. These options vest in three equal increments on 2/18/10, 2/18/11 and 2/18/12. These optons vest in three equal increments on 11/20/09, 11/20/10 and 11/20/11. These options vest in three equal increments on 10/3/09, 10/03/10 and 10/3/11. These options vest in three equal increments on 2/20/09, 2/20/10 and 2/20/11. These options vest in three equal increments on 10/1/08, 10/1/09 and10/1/10. Lisa C. Noecker attorney-in-fact for Daniel G. Darazsdi 2010-02-11